SmartCells and JDRF Partner in Diabetes Research
Posted on: Thursday, 23 October 2008, 09:00 CDT
SmartCells, a provider of polymer-based dosing technology, and the Juvenile Diabetes Research Foundation have announced a partnership to advance SmartCells's SmartInsulin for the treatment of type 1 diabetes.
As part of the agreement, the Juvenile Diabetes Research Foundation (JDRF) will provide $1 million in first-year funding to support preclinical safety and efficacy testing. The partnership is structured to support milestone-based funding through proof-of-concept human clinical trials.
Under the terms of the partnership, the $1 million dollars of funding will support testing the safety and efficacy of SmartInsulin in preclinical type 1 diabetes trials. The partnership is intended to accelerate its development and reduce the time needed to progress to human testing.
SmartInsulin will be a once-a-day, glucose-regulated subcutaneous insulin formulation for treating diabetes. SmartInsulin is injectable, like currently available insulins, but designed to maintain continuous, tight control of blood glucose levels while reducing the risk of hypoglycemia, the company said.
Aaron Kowalski, metabolic control program director of JDRF, said: "JDRF is committed to supporting the development of unique therapies that can improve metabolic control for people with type 1 diabetes. We believe that glucose-regulated insulin may represent a practical solution to the real needs of people with diabetes, and this collaboration illustrates our dedication to helping innovative companies test concepts and bring their products to patients faster."
Source: Datamonitor
Related Articles
- ARKRAY, Inc. Launches New and Improved Assure(R) Pro Blood Glucose Monitoring Test Strips
- Bayer Statement on U.S. Food and Drug Administration Advice for Patients: Serious Errors with Certain Blood Glucose Monitoring Test Strips
- Glucose Challenge Test Is Accurate and Economical For Diabetes And Prediabetes Screening
- Survey Reports Young Adults With Type 1 Diabetes Need More Social and Psychological Support
- Latest Research Has Medical Experts Considering New Testing Guidelines for Type 2 Diabetes Patients
- SmartCells, Inc. And Juvenile Diabetes Research Foundation Announce Partnership and $1 Million Funding to Advance SmartInsulin(TM) for Type 1 Diabetes
- FDA Approves JANUMET(TM) for Type 2 Diabetes, Offering Powerful Glucose Control of a DPP-4 Inhibitor and Metformin in a Single Tablet
- Memory Walk(R) Successfully Raises Awareness and Funds to Support the Mission of the Alzheimer's Association
- Diana Legacy Fund to Support Work in Sub-Saharan Africa
- The Association Between Glucose Challenge Test, Obesity and Pregnancy Outcome in 6390 Non-Diabetic Women
 |
 |
User Comments (0)
RSS Feeds